170 related articles for article (PubMed ID: 8485070)
1. Effects of trimetazidine on in vivo coronary arterial platelet thrombosis.
Belcher PR; Drake-Holland AJ; Hynd JW; Noble MI
Cardiovasc Drugs Ther; 1993 Feb; 7(1):149-57. PubMed ID: 8485070
[TBL] [Abstract][Full Text] [Related]
2. Effect of aspirin and epinephrine on experimentally induced thrombogenesis in dogs. A parallelism between in vivo and ex vivo thrombosis models.
Roux SP; Sakariassen KS; Turitto VT; Baumgartner HR
Arterioscler Thromb; 1991; 11(5):1182-91. PubMed ID: 1911705
[TBL] [Abstract][Full Text] [Related]
3. Sodium nitroprusside, an endothelium-derived relaxing factor congener, increases platelet cyclic GMP levels and inhibits epinephrine-exacerbated in vivo platelet thrombus formation in stenosed canine coronary arteries.
Rovin JD; Stamler JS; Loscalzo J; Folts JD
J Cardiovasc Pharmacol; 1993 Oct; 22(4):626-31. PubMed ID: 7505366
[TBL] [Abstract][Full Text] [Related]
4. High-dose droperidol protects against experimental coronary thrombosis in dogs and pigs and attenuates aggregation of porcine platelets and Ca2+ mobilization in human platelets.
Bertha BG; Sill JC; Berger I; Folts JD; Milde JH
Anesthesiology; 1993 Apr; 78(4):733-43. PubMed ID: 8466073
[TBL] [Abstract][Full Text] [Related]
5. Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.
Ramjit DR; Lynch JJ; Sitko GR; Mellott MJ; Holahan MA; Stabilito II; Stranieri MT; Zhang G; Lynch RJ; Manno PD
J Pharmacol Exp Ther; 1993 Sep; 266(3):1501-11. PubMed ID: 8371153
[TBL] [Abstract][Full Text] [Related]
6. Effects of MDL 28,133A, a 5-HT2 receptor antagonist, on platelet aggregation and coronary thrombosis in dogs.
Hsieh CP; Sakai K; Bruns GC; Dage RC
J Cardiovasc Pharmacol; 1994 Nov; 24(5):761-72. PubMed ID: 7532754
[TBL] [Abstract][Full Text] [Related]
7. Aurintricarboxylic acid in a canine model of coronary artery thrombosis.
Strony J; Phillips M; Brands D; Moake J; Adelman B
Circulation; 1990 Mar; 81(3):1106-14. PubMed ID: 2306818
[TBL] [Abstract][Full Text] [Related]
8. Epinephrine potentiation of in vivo stimuli reverses aspirin inhibition of platelet thrombus formation in stenosed canine coronary arteries.
Folts JD; Rowe GG
Thromb Res; 1988 May; 50(4):507-16. PubMed ID: 3413717
[TBL] [Abstract][Full Text] [Related]
9. Administration of wine and grape juice inhibits in vivo platelet activity and thrombosis in stenosed canine coronary arteries.
Demrow HS; Slane PR; Folts JD
Circulation; 1995 Feb; 91(4):1182-8. PubMed ID: 7850957
[TBL] [Abstract][Full Text] [Related]
10. Tocotrienols-induced inhibition of platelet thrombus formation and platelet aggregation in stenosed canine coronary arteries.
Qureshi AA; Karpen CW; Qureshi N; Papasian CJ; Morrison DC; Folts JD
Lipids Health Dis; 2011 Apr; 10():58. PubMed ID: 21489303
[TBL] [Abstract][Full Text] [Related]
11. Antagonism of the platelet 5HT2 receptor in the presence of thrombolysis.
Belcher PR; Drake-Holland AJ; Noble MI
Int J Cardiol; 1994 Jan; 43(1):11-20. PubMed ID: 8175214
[TBL] [Abstract][Full Text] [Related]
12. Dispersion of coronary artery thrombi by antagonism of platelet serotonin receptor in the dog.
Belcher PR; Drake-Holland AJ; Hynd J; Noble MI
Cardiovasc Res; 1992 Mar; 26(3):292-6. PubMed ID: 1423425
[TBL] [Abstract][Full Text] [Related]
13. Inhibition by the combined Ca2+ and 5-HT2 receptor antagonist nexopamil (LU 49938) of intracoronary thrombus formation in a canine model of arterial stenosis and intimal damage.
Kirchengast M; Rübsamen K; Lehmann HD
J Cardiovasc Pharmacol; 1993 Nov; 22(5):687-94. PubMed ID: 7506319
[TBL] [Abstract][Full Text] [Related]
14. Thrombin inhibition and intracoronary thrombus formation: effect of polyethylene glycol-coupled hirudin in the stenosed, locally injured canine coronary artery.
Rübsamen K; Kirchengast M
Coron Artery Dis; 1998; 9(1):35-42. PubMed ID: 9589189
[TBL] [Abstract][Full Text] [Related]
15. Redirection of arachidonic acid metabolism by ICI D1542: effects on thrombus formation in the coronary artery of the anaesthetized dog.
McAuliffe SJ; Moors JA; Snow HM; Wayne M; Jessup R
Br J Pharmacol; 1993 Apr; 108(4):901-6. PubMed ID: 8485629
[TBL] [Abstract][Full Text] [Related]
16. Combined inhibitory effects of aspirin and ethanol on adrenaline exacerbation of acute platelet thrombus formation in stenosed canine coronary arteries.
Keller JW; Folts JD
Cardiovasc Res; 1990 Mar; 24(3):191-7. PubMed ID: 2346953
[TBL] [Abstract][Full Text] [Related]
17. Sildenafil improves coronary artery patency in a canine model of platelet-mediated cyclic coronary occlusion after thrombolysis.
Lewis GD; Witzke C; Colon-Hernandez P; Guerrero JL; Bloch KD; Semigran MJ
J Am Coll Cardiol; 2006 Apr; 47(7):1471-7. PubMed ID: 16580539
[TBL] [Abstract][Full Text] [Related]
18. Combination of platelet fibrinogen receptor antagonist and direct thrombin inhibitor at low doses markedly improves thrombolysis.
Nicolini FA; Lee P; Rios G; Kottke-Marchant K; Topol EJ
Circulation; 1994 Apr; 89(4):1802-9. PubMed ID: 8149546
[TBL] [Abstract][Full Text] [Related]
19. An in vivo model of experimental arterial stenosis, intimal damage, and periodic thrombosis.
Folts J
Circulation; 1991 Jun; 83(6 Suppl):IV3-14. PubMed ID: 2040070
[TBL] [Abstract][Full Text] [Related]
20. Pathological basis of failure of concurrent glyceryl trinitrate therapy to improve efficacy of tissue type plasminogen activator in coronary thrombosis.
Nicolini FA; Nichols WW; Saldeen TG; Mehta JL
Cardiovasc Res; 1991 Apr; 25(4):283-9. PubMed ID: 1909212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]